Skip to content
Screener

LivaNova LIVN Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Abbott logo
AbbottABT
$486M+73.6%
Haemonetics logo
HaemoneticsHAE
$3.62M-42.7%
ITG
Integer HoldingsITGR
$600K+50.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$1.1M-15.4%
ResMed logo
ResMedRMD
$29.47M+48.7%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.21B+55.7%
Enterprise value$4.05B+55.9%
P/E22.8×-68.5×
P/S2.9×+0.8×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemJune 30, 2026December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents$516,619$635,552
Accounts receivable, net of allowance of $10,720 as of June 30, 2026 and $12,527 as of December 31, 2025231,303215,985
Inventories172,612164,701
Prepaid and refundable taxes42,87048,606
Prepaid expenses and other current assets61,64136,769
Total Current Assets1,025,0451,101,613

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's allowance for doubtful accounts receivable (current)?
LivaNova (LIVN) reported allowance for doubtful accounts receivable (current) of $10.72M in Q2 2026.
How has LivaNova's allowance for doubtful accounts receivable (current) changed year-over-year?
LivaNova's allowance for doubtful accounts receivable (current) decreased by 16.6% year-over-year, from $12.86M to $10.72M.
What is the long-term trend for LivaNova's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), LivaNova's allowance for doubtful accounts receivable (current) has grown at a 4.0% compound annual growth rate (CAGR), from $10.31M to $12.53M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about LivaNova's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude